日本ゲノム編集学会・第11回大会 ARCALIS: A CDMO advancing mRNA therapeutics for genome editing from mRNA design to manufacturing
TIDES USA 2026 Novel Approach for LNP Manufacturing and Formulation TechnologyDemonstrating Consistent Bioactivity and Organ-Selective Delivery at ARCALIS
第5回つくば共創の場カンファレンス ARCALIS: An integrated CDMO advancing mRNA therapeutics for the treatment of rare diseases from mRNA design to manufacturing
TIDES ASIA 2026 An Integrated CDMO Empowering the Future of mRNA-based Therapeutics from Design to Manufacturing
TIDES USA 2025 Correlation between Quality Attributes and Bioactivities of mRNA-Lipid Nanoparticles
TIDES USA 2025 Strategies to develop safe and effective mRNA-based therapeutics
日本核酸医薬学会 第10回年会 Analysis of mRNA 5’Cap Ratio Using Nuclease P1
